The Ids Have It Article uri icon

Overview

MeSH Major

  • Cancer Vaccines
  • Central Nervous System Neoplasms
  • Glioblastoma

abstract

  • In this issue of Cancer Cell, Anido et al. demonstrate that Id1 is the likely arbiter of divergent transforming growth factor-β (TGF-β) signaling in glioma-initiating cells (GICs) from different tumors. These findings hold both the promise and potential peril of therapeutic targeting of the TGF-β pathway.

publication date

  • December 14, 2010

Research

keywords

  • Article

Identity

Digital Object Identifier (DOI)

  • 10.1016/j.ccr.2010.11.028

Additional Document Info

start page

  • 543

end page

  • 5

volume

  • 18

number

  • 6